Lactobacillus rhamnosus GG and Increased Loss of Vancomycin-Resistant Enterococcus Colonization

• A randomized controlled trial of Lactobacillus rhamnosus GG on antimicrobial-resistant organism colonization.

  • 2021-04-06
  • RCT · n = 44
  • Infection control and hospital epidemiology 43(2)
  • • Adriana M Rauseo
    • Tiffany Hink
    • Kimberly A Reske
    • Sondra M Seiler
    • Kerry M Bommarito
    • Victoria J Fraser
    • Carey-Ann D Burnham
    • Erik R Dubberke

  • PubMed: 33820576
  • DOI: 10.1017/ice.2021.94

  8 Insights on

  • Increased Loss of Vancomycin-Resistant Enterococcus Colonization

  • High evidence
  • Clinical

  There was no difference in the loss of any ARO (LGG 18% vs placebo 24%; OR, 1.44; 95% CI, 0.27-7.68) nor for any individual ARO.

  Effect

  Neutral

  Effect size

  Small

  Significant

  No

  Dose

  2×10^10 cells per day